Glomerulonephritis management (management of glomerulonephritis (glomerular disease))

Ongoing specialist care for inflammation or damage of the kidney's filters, aiming to protect kidney function and treat the cause.

✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review

In short

Glomerulonephritis is a group of conditions, so treatment depends heavily on which type you have.
The aim is to protect kidney function and treat the cause, not always to 'cure' — some types relapse or progress.
Controlling blood pressure and reducing protein in the urine protect the kidneys whatever the type.
Strong immune-suppressing treatment helps some types but carries real risks, so the trade-offs must be discussed.

A plain-English summary. The detail — including risks and recovery — is below.

At a glance

TypeOngoing specialist medical care

AnaestheticNot needed for management; local anaesthetic is used for a kidney biopsy

How long it takesLong-term, with regular clinic reviews and blood and urine tests

Hospital stayMostly outpatient; occasional admission if severe

Time off workVaries; many people work normally, more if unwell or on strong treatment

When you'll see resultsResponse is judged over weeks to months by protein, blood and kidney function

On the NHS?Managed by NHS kidney units; private nephrology is used for choice or speed of access

A general guide. Your specialist will give you advice for your situation.

Best fit

Slows or prevents loss of kidney function for many people.

Pause if

One-size-fits-all treatment is not appropriate, because management depends on the specific type.

Main recovery point

The type is confirmed, often by a kidney biopsy, and a treatment plan is agreed. A biopsy has its own short recovery and monitoring.

Good aftercare

A clear, type-specific treatment plan with explained goals and risks.

Diagnosis and biopsy

The type is confirmed, often by a kidney biopsy, and a treatment plan is agreed. A biopsy has its own short...

First weeks of treatment

Kidney-protective and, where used, immune-suppressing treatment is started. Early blood and urine tests check...

First few months

Response is judged by falling protein, settling blood in the urine and stable or improving kidney function...

Ongoing

Regular clinic reviews and tests track the disease, watch for relapse and side effects, and fine-tune treatment.

Medical line illustration of the kidneys, ureters and bladder for Glomerulonephritis management. — Illustration only - not a diagnosis, medical advice or a promise of result. Your anatomy and treatment plan may differ. Vuemedics does not publish before-and-after photos.

What is glomerulonephritis management?

Glomerulonephritis means inflammation or damage of the glomeruli — the tiny filters in the kidneys. It is not one disease but a group of conditions, including IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis (FSGS) and lupus nephritis. Some are limited to the kidney; others are part of a wider condition such as lupus or vasculitis.

Management means the ongoing specialist care that follows diagnosis. It usually combines treatment of the specific cause, protecting the kidneys generally (controlling blood pressure and reducing protein in the urine), and monitoring over time. Because the types differ so much, the exact treatment depends on which one you have, often confirmed by a kidney biopsy.

The aim is to control the disease, protect kidney function and reduce the chance of long-term kidney failure. For some types this means strong immune-suppressing treatment; for others it means careful monitoring and kidney-protective measures rather than immediate drugs.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

IgA nephropathy

One of the most common types worldwide. Often managed with kidney-protective measures and blood-pressure control, with immune-suppressing treatment reserved for selected people at higher risk of progression.

Membranous nephropathy

Often causes heavy protein loss (nephrotic syndrome). Some cases improve on their own with supportive treatment; others need immune-suppressing therapy guided by risk and antibody tests.

Focal segmental glomerulosclerosis (FSGS)

Causes scarring of parts of the filters and protein loss. Treatment depends on the underlying cause and may include kidney-protective measures and, in some, immune-suppressing drugs.

Lupus nephritis

Kidney involvement in lupus. Managed jointly with rheumatology, often with immune-suppressing treatment, and needs long-term monitoring for relapse.

Vasculitis-associated (ANCA) glomerulonephritis

Part of a wider inflammatory condition that can damage the kidneys quickly. Needs prompt, often intensive immune-suppressing treatment and close monitoring.

Post-infectious glomerulonephritis

Follows certain infections, more often in children, and frequently settles with supportive care as the body recovers.

Kidney-protective care vs immune-suppressing treatment

	Kidney-protective care	Immune-suppressing treatment
Main aim	Reduce protein, control blood pressure	Calm the immune attack on the kidney
Used for	Almost all types	Selected, higher-risk types
Examples	ACE inhibitors/ARBs, salt control	Steroids, other immune-suppressing drugs
Main trade-off	Few risks, slower acting	Can work well but more side effects

Many people have kidney-protective care; immune-suppressing treatment is added only for certain types and risk levels.

Preparing for your treatment

Bring your diagnosis and biopsy result if you have them, as the exact type guides treatment.
Bring a full list of your medicines, including any immune-suppressing drugs and painkillers.
Note your recent blood pressure readings if you measure at home.
List symptoms such as swelling, frothy urine, blood in the urine, joint pains or rashes.
Mention any infections, vaccinations and whether you are planning a pregnancy, as these affect treatment choices.
Bring previous kidney-function and urine protein results to show the trend.
Write down your questions about your specific type, treatment options and risks.

What happens

A kidney specialist (nephrologist) confirms the type of glomerulonephritis, usually with blood tests, urine tests and often a kidney biopsy, then explains what it means. Management is then tailored to that type.

For most people, care includes kidney-protective measures — medicines such as ACE inhibitors or ARBs to lower blood pressure and reduce protein, salt reduction, and treatment of swelling with diuretics if needed. For certain types and higher-risk situations, immune-suppressing treatment such as steroids or other drugs is added to calm the immune attack, with careful monitoring for side effects.

You are then followed in clinic over the long term. Blood and urine tests track kidney function and protein, and treatment is adjusted according to response and side effects. Some conditions are managed jointly with other specialists, such as rheumatology for lupus.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

May not be suitable if…

One-size-fits-all treatment is not appropriate, because management depends on the specific type.
Immune-suppressing treatment is not suitable for everyone and is avoided where its risks outweigh the likely benefit.
Private stand-alone care may not be ideal for severe or rapidly progressing disease, which usually needs an NHS kidney unit.
It is not a quick fix; some types relapse or progress despite good treatment.

Delay or rearrange if…

You have an active infection, which may need treating before starting or increasing immune-suppressing therapy.
You are pregnant or planning pregnancy, as several treatments are unsafe and the plan must be reviewed.
You have unstable symptoms such as rapidly worsening swelling or breathlessness — these need urgent assessment, not a routine delay.
Key results, such as a biopsy or antibody tests, are not yet available to guide treatment.

Alternatives to discuss

Kidney-protective measures and monitoring alone for lower-risk types, rather than immune-suppressing drugs.
Treating an underlying condition (such as lupus or vasculitis) through joint specialist care.
Supportive care and watchful monitoring where the condition may settle on its own.
Standard NHS nephrology care, often shared even when some appointments are private.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

What matters most to me?

Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.

What are all my options?

Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.

What would make me pause?

Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.

What happens if I do nothing today?

For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.

Comfort, sedation or contrast choices

If local anaesthetic, sedation, contrast or pain relief is used, ask what is planned, why, and what it means afterwards.

Local anaesthetic for a kidney biopsy

Used to numb the skin and tissue if a biopsy is needed to confirm the type of glomerulonephritis.

Benefits

Slows or prevents loss of kidney function for many people.
Reduces protein in the urine, an important driver of kidney damage.
Treats the underlying cause in types that respond to immune-suppressing therapy.
Controls symptoms such as swelling and high blood pressure.
Monitors for relapse so treatment can be restarted early.
Coordinates care with other specialists when the condition is part of a wider illness.

Risks & complications

More common

Side effects of kidney-protective medicines, such as a cough, dizziness or changes in blood tests.
Side effects of steroids, including weight gain, mood changes, raised blood sugar and disturbed sleep.
The need for frequent blood and urine tests and clinic visits.

Less common

Higher risk of infections while on immune-suppressing treatment.
Effects of long-term steroids on bones, blood pressure and the eyes.
Relapse of the condition needing further or stronger treatment.

Rare but serious

Serious infections or other complications of strong immune-suppressing treatment.
Progression to kidney failure needing dialysis or a transplant despite treatment.
Complications of a kidney biopsy, such as significant bleeding.

The biggest uncertainties are which type you have, how it will behave over time, and whether the benefit of immune-suppressing treatment outweighs its risks for you. Some types relapse or progress despite good treatment. Strong immune-suppressing drugs can help but raise the risk of infection and other side effects. Ask your nephrologist about your specific type, your personal risk of kidney decline, and exactly what each treatment is expected to achieve.

Published figures to discuss

Outcomes vary enormously between the different types of glomerulonephritis, by how much kidney damage is present at diagnosis, the amount of protein in the urine and how well blood pressure is controlled. Because of this, single percentages for 'cure', relapse or progression are not meaningful across the group and could mislead. Your nephrologist should give figures specific to your confirmed type and your individual situation rather than a generic rate.

Figure	Reported range	How to interpret it	Source / confidence
Rapidly progressive kidney failure	Condition-dependent emergency	Rising creatinine, heavy proteinuria, active urine sediment or systemic symptoms may need urgent nephrology review.	NHS — Glomerulonephritisnhs.ukSource-linked context
Kidney biopsy bleeding	Uncommon but important	Biopsy decisions balance diagnostic value against bleeding risk, blood pressure and anticoagulants.	NHS — Glomerulonephritisnhs.ukSource-linked context
Immunosuppression infection risk	Drug- and dose-dependent	Steroids, rituximab, cyclophosphamide and other drugs need vaccination, infection and monitoring plans.	NHS — Glomerulonephritisnhs.ukSource-linked context
Relapse after remission	Disease-specific	IgA nephropathy, vasculitis, lupus nephritis and membranous nephropathy behave differently and need tailored follow-up.	Guide sourcesClinical context

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Glomerulonephritis is managed over the long term rather than 'recovered from' in one go. 'Afterwards' means how your kidneys respond to treatment, judged over weeks to months, and how the condition is monitored.

Diagnosis and biopsy

The type is confirmed, often by a kidney biopsy, and a treatment plan is agreed. A biopsy has its own short recovery and monitoring.

First weeks of treatment

Kidney-protective and, where used, immune-suppressing treatment is started. Early blood and urine tests check tolerance and any early response.

First few months

Response is judged by falling protein, settling blood in the urine and stable or improving kidney function. Treatment is adjusted accordingly.

Ongoing

Regular clinic reviews and tests track the disease, watch for relapse and side effects, and fine-tune treatment.

Long term

Some people reach stable, low-treatment maintenance; others need continued or repeated treatment, and a minority progress despite care.

What's normal — and not a worry

Slow, gradual change in protein and blood-test results rather than an instant cure.
Side effects from medicines that often settle or are managed as treatment continues.
Periods of stability interrupted by occasional relapses in some types.
Needing regular blood and urine tests even when you feel well.

Aftercare

Take your medicines exactly as prescribed and do not stop immune-suppressing drugs suddenly.
Attend all blood and urine tests so kidney function and protein can be tracked.
Keep your blood pressure well controlled, including any home monitoring asked of you.
Reduce added salt and follow any dietary advice from your team.
Be cautious with anti-inflammatory painkillers, which can harm the kidneys.
Watch for and report signs of infection promptly if you are on immune-suppressing treatment.
Keep up recommended vaccinations and discuss any planned pregnancy in advance.
Report new swelling, heavy frothing of urine, blood in the urine or a sudden drop in urine output.

Before your treatment

Diagnosis and biopsy result to hand
Up-to-date medicines list
Home blood pressure readings if monitored
Record of recent kidney-function and protein results
Note of any infections or vaccinations
Pregnancy plans discussed if relevant
Questions about your specific type and treatment written down

⚠ Get urgent help if…

A sudden, large drop in how much urine you pass.
Rapidly worsening swelling of the legs, face or body.
Breathlessness or chest symptoms (possible fluid overload).
Signs of serious infection while on immune-suppressing treatment: high fever, feeling very unwell.
Heavy blood in the urine or sudden, severe loin pain.
Confusion, drowsiness or feeling extremely unwell.
Severe pain or heavy bleeding after a kidney biopsy.

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good outcome is stable or improving kidney function with reduced protein in the urine and, where relevant, the underlying disease brought under control. For some types, the condition settles and treatment can be reduced; for others, the aim is long-term control and slowing progression.

Management cannot guarantee a cure or that kidney function will never decline. Some types relapse or progress despite the best treatment. Honest follow-up tracks the trend so that treatment can be adjusted and complications caught early.

How long it lasts

How the condition behaves over years depends on the type, how much kidney damage was present at diagnosis, the amount of protein in the urine and how well blood pressure is controlled. Some people remain stable for decades; others progress towards kidney failure and may eventually need dialysis or a transplant. Long-term monitoring is therefore part of management, even during stable periods.

Related tests, treatments or support

Management often combines treatment of the specific kidney disease with general kidney protection and cardiovascular risk reduction, and with care from other specialists — for example rheumatology for lupus or vasculitis. Investigation of blood and protein in the urine usually leads into this management, and ongoing assessment continues alongside it.

Follow-up & long-term care

You are followed in a kidney clinic with regular blood and urine tests to track kidney function, protein and disease activity, and to monitor treatment side effects. Reviews are more frequent during active disease or treatment changes and less frequent when stable. You should be told who to contact between appointments if you become unwell or notice warning signs.

Continue kidney-protective medicines (such as ACE inhibitors or ARBs) long term where prescribed.
Attend regular monitoring of kidney function, protein and disease activity.
Have the bone, blood-pressure and blood-sugar checks needed with long-term steroids.
Keep vaccinations up to date and reduce infection risk while immune-suppressed.
Maintain blood pressure control and a low-salt diet.
Review treatment with your nephrologist before any planned pregnancy.

Repeat, follow-on and what comes next

Treatment is often adjusted, switched or escalated depending on response and side effects.
Some types relapse and need treatment restarted, sometimes more than once.
A repeat kidney biopsy is occasionally needed to reassess if the picture changes.
A minority progress towards kidney failure despite treatment and move to planning for dialysis or transplant.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

A clear, type-specific treatment plan with explained goals and risks.
Regular monitoring of kidney function, protein and disease activity, plus treatment side effects.
A relapse plan and clear advice on warning signs and infection risk while immune-suppressed.
A named contact, coordinated shared care where needed, and review before any planned pregnancy.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

Number and length of specialist consultations over time.
Whether a kidney biopsy is needed and its laboratory analysis.
Blood and urine tests, which are frequent during active disease.
Medicines used, including kidney-protective drugs and immune-suppressing treatment.
Monitoring required with immune-suppressing or steroid treatment.
Input from other specialists, such as rheumatology, where the condition is part of a wider illness.

Make sure your written quote includes

The nephrologist consultation fee, including follow-up appointments.
Cost of a kidney biopsy and its analysis if needed.
Laboratory fees for the regular blood and urine tests.
Cost of medicines and of the monitoring that immune-suppressing treatment requires.
Any costs for shared care with other specialists.
What happens, and what it costs, if the condition relapses or progresses and needs more treatment.

On the NHS? Glomerulonephritis is managed by NHS kidney units when clinically indicated; private nephrology is sometimes used for a faster appointment, choice of specialist or a second opinion, though complex care is usually shared with an NHS unit.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Choosing a specialist safely

Check the specialist is on the GMC Specialist Register for this area.
Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Questions to ask your medical professional

Take this to your consultation. A good specialist will welcome every one of these.

Which type of glomerulonephritis do I have, and how was it confirmed?
What is my personal risk of losing kidney function over time?
What is each treatment expected to achieve, and what are its main risks?
Do I need immune-suppressing treatment, or mainly kidney-protective measures?
How will we know if treatment is working or if the condition relapses?
What should I avoid, and who do I contact if I become unwell or notice warning signs?
Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
Will you be the specialist who carries out my treatment, and who looks after me afterwards?
What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
What does a realistic result look like — and what can this treatment not achieve?
What are my options, including waiting, doing nothing for now, or choosing a different approach?
Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Frequently asked questions

Is glomerulonephritis one disease?

No. It is a group of conditions affecting the kidney's filters, including IgA nephropathy, membranous nephropathy, FSGS and lupus nephritis. Treatment depends a lot on which type you have, which is why a kidney biopsy is often needed.

Will I need a kidney biopsy?

Often, yes. A biopsy usually confirms the exact type and guides treatment. It is done with local anaesthetic and has a short recovery. Your nephrologist will explain whether it is needed in your case.

Do I have to take steroids?

Not always. Many people are managed mainly with kidney-protective measures. Steroids or other immune-suppressing drugs are used for certain types and higher-risk situations, where the benefit is judged to outweigh the side effects.

Can it be cured?

Some types settle and treatment can be reduced; others are long-term conditions that can relapse or progress. The aim is to control the disease and protect kidney function rather than promise a cure.

Could I end up needing dialysis?

A minority of people progress to kidney failure despite treatment and may eventually need dialysis or a transplant. Good control of protein and blood pressure, and early treatment, reduce that risk. Your team can discuss your individual outlook.

Can I have this managed on the NHS?

Yes. Glomerulonephritis is managed by NHS kidney units. Private nephrology is sometimes used for a faster appointment, choice of specialist or a second opinion, but complex care is usually shared with an NHS unit.

Find a verified specialist for glomerulonephritis management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

No verified consultants list this procedure yet — browse the full directory.

See all specialists for glomerulonephritis management →

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Glomerulonephritis NHS — Glomerulonephritis: treatment UK Kidney Association — Commentary on KDIGO 2021 glomerular disease guideline Kidney Care UK — IgA nephropathy Kidney Care UK — Membranous nephropathy

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.